T1	Participants 15 37	chronic heart failure:
T2	Participants 358 400	two large populations of patients with HF.
T3	Participants 496 656	1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA) and 1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF).
T4	Participants 1715 1739	patients with chronic HF
